The Copenhagen Post | Novo stock surges on rival’s weak sales data by Ritzau

AI generated summary, Read the full article for complete information.

Novo Nordisk’s shares rose 5.4 % after data showed rival Eli Lilly’s new weight‑loss pill Foundayo delivered only 3,707 prescriptions in its second week, far fewer than Novo’s oral version of Wegovy, which recorded 18,410 prescriptions during the same period, prompting analysts to view Lilly’s launch as weak and boosting confidence in Novo’s product.

Read more: https://cphpost.dk/2026-04-25/business-education/business-business-education/novo-stock-surges-on-rivals-weak-sales-data/

#NovoNordisk #EliLilly #Foundayo #Wegovy #business #SørenLøntoftHansen

AI generated summary, Read the full article for complete information.

FDA Approves Foundayo: The New Once-Daily GLP-1 Pill vs. Wegovy

https://www.dietofcommonsense.com/fda-approved-foundayo-for-weight-loss/

#GLP1 #GLP1pil #wegovy #foundayo #health #weightlosspills

Foundayo vs. Wegovy Pill: 2026 Comparison of Weight Loss Pills, Cost, and Results

https://www.dietofcommonsense.com/foundayo-vs-wegovy-pill-weight-loss/

#foundayo #wegovy #weightloss #weightlosspill #health

#FDA Approves #Foundayo: The New Once-Daily GLP-1 Pill vs. #Wegovy

As the second oral #GLP1 pill to hit the market—following the December 2025 approval of the Wegovy pill — Foundayo is being hailed as a “game-changer” for its unique dosing flexibility.

https://www.dietofcommonsense.com/fda-approved-foundayo-for-weight-loss/

#Foundayo vs. #Wegovy Pill: 2026 Comparison of #WeightLoss Pills, Cost, and Results

For millions of #Americans, the shift from weekly injections to a daily pill isn’t just about avoiding a poke—it’s about cost and lifestyle flexibility.

https://www.dietofcommonsense.com/foundayo-vs-wegovy-pill-weight-loss/

Why Novo Nordisk’s Weight Loss Pill Has Taken Off

https://vid.freedif.org/w/87SKdNnd3zKBYnKR9BgLck

FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo

📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101

#health #obesity #glp1 #foundayo

FDA grants full approval to Eli Lilly’s once‑daily GLP‑1 obesity pill Foundayo

📰 Original title: FDA Approves Eli Lilly’s GLP-1 Pill

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/fda-grants-full-approval-to-eli-lillys-once-daily-glp-1-obesity-pill-foundayo/?redirpost=292e6cab-5cb7-4569-b53a-e6d70a567101

#health #obesity #glp1 #foundayo

Update: New Options for Weight Loss

The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.

https://bit.ly/4sbhJVl
#obesity #WeightLoss